If you have a special discount code for this program, please choose the Standard Price shown below. You'll be prompted to enter your member code once in the shopping cart.
Total Credits: 1 Standalone Webinar 1.0 CME
The presentation will review developmental aspects of substance use and exposure. Dr. Raymond Bunch will discuss neurodevelopmental contributors and biopsychosocial risks. The session will conclude with a review of medication-assisted treatment and psychotherapeutic modalities.
At the conclusion of this activity, learners will be able to:
Dr. Bunch and Dr. Yoblonski have no relevant financial relationships to disclose. AzAAP gratefully acknowledges financial support for this ECHO series from the University of Arizona Department of Psychiatry.
| ECHO Session 7 Verification Requirements (232.5 KB) | Available after Purchase | ||
| Arizona Pediatric Access Line Flyer (432.3 KB) | Available after Purchase | ||
Dr. Yoblonski has worked at Phoenix Childrens Hospital in the Homeless Youth Outreach program and the Center for Resiliency and Wellbeing for the past eleven years. She currently works with homeless youth and families, foster children and youth, and survivors of sex trafficking. Trauma informed care is an area of interest due to the patients she works with. She has been working with the AzAAP Emotional and Behavioral Health Committee for the past two years.
Dr. Bunch completed school of medicine, residency training in psychiatry, fellowships in child & adolescent psychiatry and addiction psychiatry at the University of Colorado and Health Sciences center. Since 2006, he has worked clinically and taught pediatric and psychiatric residents, medical students, and fellows during rotations in consultation liaison, inpatient psychiatry, and in various ambulatory settings such as homeless clinics. This has involved students from Banner, Maricopa, University of Arizona, Mayo Clinic and Creighton School of Medicine, as well as pediatric residents from Phoenix Children’s. He assisted and continues to assist with the successful launch of the Child Adolescent Psychiatry Fellowship and development of the addiction component. He has expanded his interest into addictions and has assisted staff at UMOM, emergency room physicians, and adolescent medicine physicians in establishing and increasing services in the homeless setting.
His research experience is primarily in substance abuse, where he developed his honors thesis in undergraduate concerning the molecular biology of cigarette smoking and subsequently helped develop a study concerning physician advice and nicotine use in the pediatric population. In August, a trial was approved by our IRB concerning: Phoenix Children’s IRB # IRB-23-418: Substance Use and Problematic Electronic Use and Referral to Treatment in Patients Evaluated for Danger to Self and/or Suicidality in the Emergency Department. He most recently presented for PALS (Parents of Addicted Loved Ones).
